Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Vanholder

Showing results (41-50 of 297) with videos related to

Pageof 30
Sort By:
Idrugs : the Investigational Drugs Journal|July 29, 2005
Drug therapy of acute renal failureN Lameire, R Vanholder
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Recombinant hirudin: clinical pharmacology and potential applications in nephrologyR Vanholder, A Dhondt
Journal of the American Society of Nephrology : JASN|March 1, 1993
Infectious morbidity and defects of phagocytic function in end-stage renal disease: a reviewR Vanholder, S Ringoir
Artificial Organs|April 1, 1987
Influence of reuse and of reuse sterilants on the first-use syndromeR Vanholder, S Ringoir
Mineral and Electrolyte Metabolism|February 22, 2000
Intradialytic parenteral nutrition in malnourished hemodialysis patients. Review of the literatureA K Mortelmans, R Vanholder
Blood Purification|September 11, 2002
Incidence of infectious morbidity and mortality in dialysis patientsR Vanholder, W Van Biesen
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 3, 2012
Crush recommendations: a step forward in disaster nephrologyR Vanholder, M S Sever
Circulation|January 5, 2012
Letter by Van Laecke and Vanholder regarding article, "Risk of recurrent cardiac events after onset of menopause in women with congenital long-QT syndrome types 1 and 2"S Van Laecke, R Vanholder
Journal of the American Society of Nephrology : JASN|August 14, 1999
Pathophysiologic effects of uremic retention solutesR Vanholder, R De Smet
Lancet (London, England)|January 8, 1977
Recurrent agranulocytosis after levamisoleR Vanholder, W Van Hove
Pageof 30

Showing results (41-50 of 297) with videos related to

Sort By:
Pageof 30
Idrugs : the Investigational Drugs Journal|July 29, 2005
Drug therapy of acute renal failureN Lameire, R Vanholder
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Recombinant hirudin: clinical pharmacology and potential applications in nephrologyR Vanholder, A Dhondt
Journal of the American Society of Nephrology : JASN|March 1, 1993
Infectious morbidity and defects of phagocytic function in end-stage renal disease: a reviewR Vanholder, S Ringoir
Artificial Organs|April 1, 1987
Influence of reuse and of reuse sterilants on the first-use syndromeR Vanholder, S Ringoir
Mineral and Electrolyte Metabolism|February 22, 2000
Intradialytic parenteral nutrition in malnourished hemodialysis patients. Review of the literatureA K Mortelmans, R Vanholder
Blood Purification|September 11, 2002
Incidence of infectious morbidity and mortality in dialysis patientsR Vanholder, W Van Biesen
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 3, 2012
Crush recommendations: a step forward in disaster nephrologyR Vanholder, M S Sever
Circulation|January 5, 2012
Letter by Van Laecke and Vanholder regarding article, "Risk of recurrent cardiac events after onset of menopause in women with congenital long-QT syndrome types 1 and 2"S Van Laecke, R Vanholder
Journal of the American Society of Nephrology : JASN|August 14, 1999
Pathophysiologic effects of uremic retention solutesR Vanholder, R De Smet
Lancet (London, England)|January 8, 1977
Recurrent agranulocytosis after levamisoleR Vanholder, W Van Hove
Pageof 30